Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from the National Medical ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Jim Higgins has an inherited cancer syndrome that has killed his father, sister, and two daughters. He fears NIH cuts will ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...